Current Cancer Drug Targets

Editor-in-Chief:

Ruiwen Zhang
Center for Drug Discovery
University of Houston
3455 Cullen Blvd.
Houston, TX 77204
USA

Back

Most Accessed Articles

Antibody Based EpCAM Targeted Therapy of Cancer, Review and Update

Volume: 18   Issue: 9
Pp: 857-868
Shirin Eyvazi, Safar Farajnia*, Siavoush Dastmalchi, Farzad Kanipour, Habib Zarredar and Mojghan Bandehpour
DOI: 10.2174/1568009618666180102102311

Ponatinib: A Review of Efficacy and Safety

Volume: 18   Issue: 9
Pp: 847-856
Fulvio Massaro, Matteo Molica and Massimo Breccia*
DOI: 10.2174/1568009617666171002142659

p53-Mdm2 Interaction Inhibitors as Novel Nongenotoxic Anticancer Agents open access plus

Volume: 18   Issue: 8
Pp: 749-772
Surendra Kumar Nayak*, Gopal L. Khatik, Rakesh Narang, Vikramdeep Monga and Harish Kumar Chopra
DOI: 10.2174/1568009617666170623111953

Degradation of Androgen Receptor through Small Molecules for Prostate Cancer

Volume: 18   Issue: 7
Pp: 652-667
Raoling Ge, Xi Xu, Pengfei Xu, Lei Li, Zhiyu Li* and Jinlei Bian*
DOI: 10.2174/1568009617666171107103936

Immunomodulatory Drugs (IMiDs) in Multiple Myeloma

Volume: 17   Issue: 9
Pp: 846-857
Shahzad Raza, Rachael A. Safyan and Suzanne Lentzsch*
DOI: 10.2174/1568009617666170214104426

Autophagy as a Potential Therapeutic Target in Breast Cancer Treatment

Volume: 18   Issue: 7
Pp: 629-639
Natalia Lisiak*, Ewa Toton and Maria Rybczynska
DOI: 10.2174/1568009617666171114143330

A Comprehensive Outline of Trastuzumab Resistance Biomarkers in HER2 Overexpressing Breast Cancer open access plus

Volume: 15   Issue: 8
Pp: 665-683
Otília Menyhart, Libero Santarpia and Balazs Gyorffy
DOI: 10.2174/156800961508151001101742

Paclitaxel Resistance: Molecular Mechanisms and Pharmacologic Manipulation promotion: free to download

Volume: 3   Issue: 1
Pp: 1-19
R. Z. Yusuf, Z. Duan, D. E. Lamendola, R. T. Penson and M. V. Seiden
DOI: 10.2174/1568009033333754